OGS582

PSF-MINCMV-ZEO - MINIMAL CMV ZEOCIN RESISTANT PLASMID

plasmid vector for molecular cloning

• 別名: cloning vector, expression vector, molecular cloning vector, plasmid, plasmid vector, snapfast vector, vector
• NACRES: NA.85
• UNSPSC Code: 12352200
• Promoter: Promoter name: CMV; Promoter activity: minimal promoter; Promoter type: mammalian
• Origin of replication: pUC (500 copies)
• Bacteria selection: kanamycin
• Reporter gene: none
• Peptide cleavage: no cleavage

特性

• form: buffered aqueous solution
• mol wt: size 4105 bp
• bacteria selection: kanamycin
• mammalian cells selection: Zeocin^®
• origin of replication: pUC (500 copies)
• peptide cleavage: no cleavage
• promoter: Promoter name: CMV; Promoter activity: minimal promoter; Promoter type: mammalian
• reporter gene: none
• shipped in: ambient
• storage temp.: −20°C

詳細

General description

PSF-MINCMV-ZEO - MINIMAL CMV ZEOCIN RESISTANT PLASMID has the Zeocin resistance gene under transcriptional control of the minimal CMV promoter giving basal expression in most mammalian cells. Expression levels can be influenced by inserting additional regulatory elements upstream of the minimal promoter using a specially-positioned MCS for example to provide dependence on cell-associated transcription factors or externally applied drugs such as doxycycline. In this way a range of sophisticated constructs can be prepared that endow Zeocin resistance only under specific conditions.

Promoter Expression Level: This plasmid vector contains the minimal CMV immediate early promoter with a multiple cloning site immediately upstream that allows transcription factor binding sites to be inserted. This allows tissue specific or physiologically responsive promoters to be created.

Application

Cloning in a gene: PSF-MINCMV-ZEO - MINIMAL CMV ZEOCIN RESISTANT PLASMID contains a gene within the main multiple cloning site (NotI-ClaI). Any plasmid that we sell where the gene is this configuration will be located in the exact same position in relation to the start and stop codon of the gene. The only exceptions to this rule are fusions proteins where the fusion gene may be positioned at the front or end of the MCS to allow gene fusion.

By positioning all of our genes in the same location it allows them to be transferred between plasmids using the same cloning method and restriction sites regardless of the plasmid being used from our product range. Inserting a new gene into this plasmid should be easily possible using a range of standard restriction enzyme sites that flank the gene currently in the vector.

Multiple cloning site notes: In the multiple cloning site there are two important restriction sites called BsgI and BseRI sites. These sites both cut the DNA at the same position and cleave the stop codon of the gene in the multiple cloning site in this plasmid thereby producing a TA overhang. This overhang is compatible with any of our peptide or reporter fusion tag plasmids also cut with either of these enzymes. This allows seamless C-terminal fusions to be made with the gene in this multiple cloning site using a single cloning step from our C-terminal peptide and reporter tag product range. Normally the easiest method is to clone the C-terminal tag from our other plasmid products into this plasmid using BsgI or BseRI and the downstream ClaI restriction site.

BseRI and BsgI sites are non-palindromic and cleave a defined number of bases away from their binding sites. This allows them to cut the upstream stop codon in the gene in this plasmid regardless of the gene sequence.

Analysis Note

To view the Certificate of Analysis for this product, please visit www.oxgene.com

Other Notes

Quick-reference Plasmid Map

Legal Information

Zeocin is a registered trademark of Cayla Sarl

安全性情報

• 保管分類: 12 - Non Combustible Liquids
• flash_point_f: Not applicable
• flash_point_c: Not applicable